# Phase 14: internal review findings

Prepared 3 October 2026 for draft [PR #29](https://github.com/swardhan-del/wardhan-medical-study-guide-studios/pull/29), branch `feat/phase-twelve-lesson-preview`.

**This is AI-assisted internal source/editorial triage, NOT independent clinical peer review, human accessibility approval, visual-rights approval, or release evidence.** No reviewer credentials, completed human-review dates or approval records are created by this document. The [review packets](reviews/phase-fourteen-eight-lesson-review-packets.md) are preparation material, not review evidence.

## Scope and basis

This record consolidates the findings in the [Phase 13 source-consistency audit](PHASE_THIRTEEN_SOURCE_CONSISTENCY_AUDIT.md) and checks their continuity with the [Phase 14 queue](PHASE_FOURTEEN_REVIEW_QUEUE.md). The starting branch commit is `a8b1c555a55e9225b1af5271a2671df873c3d3da`; its lesson content, questions, visual layouts and source metadata are unchanged from Phase 13 checkpoint `e4b09f45c3b0e6dd8ff58fe6840292b0da3f30cc`. The first documentation commit in this continuation, `411315478a0131e5d736bcf182e1da1805350cab`, adds only the review-packet file.

No new factual correction was identified beyond the source-backed Phase 13 corrections and source-support improvements recorded below. This is the outcome of this limited internal reconciliation, not a guarantee that the lessons contain no remaining errors. The prior audit records the public sources consulted and its access limitations; this document does not claim a new external-source verification, clinical assessment or completed human review. Qualified reviewers must still inspect the actual text, worked examples, questions and visuals on the exact commit they assess.

## Findings by lesson

| Lesson route | Internal finding and retained Phase 13 work | Remaining human review focus |
| --- | --- | --- |
| `/library/fluid-and-membrane-transport` | No additional factual correction identified. The earlier audit retained the distinction between permeability and driving force, channel/carrier and transport mechanisms, and the osmolarity/tonicity qualifications. | Verify objectives, electrochemical and osmotic assumptions, mechanisms, worked examples and all option feedback. |
| `/library/membrane-potentials` | The Phase 13 cable-boundary qualification is retained in teaching text and the visual caption: an ideal uniform cable without a nearby end boundary. Its voltage-sign and time/length-constant checks remain the documented basis; no additional correction identified. | Recompute calculations with units and signs; review equilibrium versus resting potential and the limits of the passive model. |
| `/library/biophysics-action-potentials` | No additional factual correction identified. Phase 13 retained the channel-state, refractory, local-current and propagation explanations with cell-model qualifications. | Review channel availability and recovery, myelination, and neuron versus ventricular comparisons without assuming a universal waveform. |
| `/library/synaptic-integration` | The Phase 13 passive-sum wording distinguishes the stipulated result from the peak of a regenerative spike. The shunting labels specify reversal potential near resting membrane voltage, and the release prompt identifies upstream steps. No further correction identified. | Review calcium-triggered release, receptor effects, summation assumptions and conductance/reversal-potential reasoning in questions and visuals. |
| `/library/muscle-contraction` | The Phase 13 isometric-contraction wording specifies constant overall muscle length rather than fixed external load. The supporting muscle-type and coupling references remain in place; no further correction identified. | Check end plate versus action potential, skeletal triad, ATP roles and skeletal/cardiac/smooth distinctions. |
| `/library/connective-tissue` | Phase 13 strengthened source support for existing preparation limitations, including lipid extraction and mineral removal. The limitations of text-only schematics remain explicit; no additional factual correction identified. | Review cell–matrix identification and preparation effects. A schematic must not be treated as proof of staining, protein expression, mineral density or measured thermogenesis. |
| `/library/somatosensory-pathways` | No additional factual correction identified. Phase 13 retained the crossing/laterality sequence, VPL/VPM distinctions and the fictional lesion's stated scope; experimental thalamic evidence was not presented as human clinical validation. | Trace DCML versus anterolateral crossings and body/face relays; check the approximate sensory boundary and that the fictional example is not diagnostic advice. |
| `/library/genetics-genome-foundations` | Phase 13 added the pangenome reference, aligned bibliography/source records and strengthened citations for genetic-test scope. The stipulated inheritance calculation and qualified VUS language remain; no further correction identified. | Check genome/reference/pangenome terminology, the assumptions behind `Aa × Aa`, per-pregnancy probabilities, testing limitations and uncertainty language. |

## Cross-lesson source and visual findings

- **Bibliography/source alignment:** Phase 13 aligned the visible bibliography and structured quality-source URL sets across all eight drafts, including previously omitted supporting references. This establishes metadata consistency, not clinical approval or assurance that every claim has adequate support.
- **Visual supporting citations:** Phase 13 made mapped supporting references visible beside the original visual layouts, with duplicate URLs removed. The citations aid review; they are not approval of scientific suitability or commercial publication rights.
- **Preparation limitations and genetic-test scope:** Phase 13 added specific supporting sources for explanations already present. This continuation records those improvements without claiming new lesson text or fresh external-source access.
- **Remaining scope:** accountable reviewers must still check objectives, claims, calculations, every answer/explanation, visual labels/captions/accessible descriptions, and source/rights decisions. Source-access limitations from the prior audit remain relevant. Raw source documents and unapproved STEM images remain private.

## Unchanged gates and disposition

### Subsequent technical continuation from `f9f95e4`

The earlier findings above remain a historical triage checkpoint. A later, broader technical pass identified enlarged-text page overflow, a duplicate genetics visual landmark name, and an inappropriate chemical-synapse supporting reference on the neuronal-conductance figure. These concrete presentation/reference corrections and their verification are recorded in [technical readiness](PHASE_FOURTEEN_TECHNICAL_READINESS.md). The lesson teaching and questions themselves are unchanged in this continuation; it does not claim a new independent medical audit.

The queue now includes the haemostasis upgrade as item 9. No professor's signed, version-bound review was located in the available files, so no clinical coverage, qualifications, dates or acceptance are recorded. Existing original-file permission is reconciled for 20 unchanged media derivatives only; current visual scientific/release decisions and human editorial/readability/accessibility approval remain pending. None of these technical records is release evidence.

All nine `medical-review-pending`, `rights-review-pending`, and `noindex-pending-review` gates remain unchanged. Human editorial/readability/accessibility review remains pending. Review-evidence fields, evidence records and review dates are unchanged; this internal triage must not be entered as independent review or release evidence.

Disposition: technical corrections and evidence reconciliation prepared for qualified human review, with no release approval. Lesson teaching, question IDs, answers and their order, routes, progress data and visual asset bytes are unchanged; presentation and the one supporting reference changed as recorded above. PR #29 remains a draft. No merge, production deployment or indexing change is authorised by this work. Use the queue's version-bound record requirements and review one route at a time; any later evidence must apply to the actual content version and assessed scope.

A qualified human reviewer must review each lesson on the exact PR #29 commit, record version-bound findings, then any correction must be re-reviewed before merge or indexing.
